Medigene (MDG1.DE) Stock Price
Medigene Price
Revenue at Medigene has contracted by 3.8% per year over the past 19 years to 6.03 M EUR. For Medigene, the net margin of -268.1% is down versus -187.8% a few years ago.
Medigene stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Medigene business model & stock analysis
Frequently asked questions about Medigene
7 analysts currently rate the Medigene stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Medigene to generate revenue of 8.16 M EUR and earnings per share of -0.55 EUR.
The Medigene share (MDG1.DE) is listed on 10 stock exchanges, including: London (0QGJ.L), SIX (Zürich) (MDG1.SW), XETRA (MDG1.DE), Frankfurt (MDG1.F), München (MDG1.MU), Düsseldorf (MDG1.DU), Hamburg (MDG1.HM), Wien (MDG1.VI).
The expected revenue of Medigene is 8.16 M EUR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Medigene is -6.73 M EUR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Medigene is currently -0.03. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Medigene stock.
The price-to-sales ratio (P/S) of Medigene is currently 0.03. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Medigene stock.
The Eulerpool Quality Score for Medigene is 2/10.
The ISIN of Medigene is DE000A40ESG2. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Medigene is A1X3W0. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Medigene is MDG1.DE. The ticker symbol is used to trade Medigene shares on the stock exchange.
Medigene stock
Medigene Peer Group
Medigene Ticker
All fundamentals and in-depth analysis of Medigene
Our stock analysis for Medigene stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medigene. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.